D-Kimia

D-Kimia is a company focused on developing innovative diagnostic solutions aimed at detecting a wide array of diseases through the identification of specific nucleic acid signatures. Utilizing advanced technology, D-Kimia creates diagnostic tests that employ gold nanoparticles to accurately detect particular nucleic acid sequences. This approach offers a more affordable and simplified means for patients suffering from diseases like hepatitis C to manage and control their conditions effectively. Through its pioneering methods, D-Kimia seeks to enhance the accessibility and efficiency of disease diagnosis and management.